Drug–Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy
Molecular Pharmaceutics · 04.11.2024 · 21 (11) · 5716-5727
DOI: 10.1021/acs.molpharmaceut.4c00733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 11.10.2024. Verfasst von Yue-Ming Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science, Qingdao, Shandong 266234, PR China. Hauptthemen laut MEDLINE: Fluorouracil, Alloys, Cytarabine, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Development Plan of the Youth Innovation Team in Colleges and Universities of Shandong Province.
Abstract (Originalsprache)
An integrated strategy by combining cocrystallization with nanotechnology is developed to optimize in vitro/vivo performances of marine antitumor drug cytarabine (ARA) and further obtain innovative insights into the exploitation of cocrystal alloy nanoformulation. Therein, the optimization of properties and synergistic effects of ARA mainly depends on assembling with uracil (U) and antitumor drug 5-fluorouracil (FU) into the same crystal by cocrystallization technology, while the long-term efficacy is primarily maintained by playing the superiority of nanotechnology. Along this line, the first cocrystal alloy of ARA, viz., ARA-FU-U (0.6:0.4), is successfully obtained and then transformed into a nanocrystal. Single-crystal X-ray diffraction analysis demonstrates that this cocrystal alloy consists of two isomorphic cocrystals of ARA, namely, ARA-FU and ARA-U, in 0.6:0.4 ratio. An R22(8) hydrogen-bonding cyclic system formed by a cytosine fragment of ARA with U or FU can protect and stabilize the amine group on ARA, laying the foundation for regulating its properties. The in vitro/in vivo properties of the cocrystal alloy and its nanocrystals are investigated by theoretical and experimental means. It reveals that both the alloy and nanocrystal can improve physicochemical properties and promote drug absorption, thus bringing to optimized pharmacokinetic behaviors. The nanocrystal produces superior effects than the alloy that helps to extend therapeutic time and action. Particularly, relative to the corresponding binary cocrystal, the synergistic antitumor activity of ARA and FU in the cocrystal alloy is heightened obviously. It may be that U contributes to reducing the degradation of FU, specifically increasing its concentration in tumors to enhance the synergistic effects of FU and ARA. These findings provide new thoughts for the application of cocrystal alloys in the marine drug field and break fresh ground for cocrystal alloy formulations to optimize drug properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science, Qingdao, Shandong 266234, PR China.
- School of Medicine, Linyi University, Linyi, Shandong 276000, PR China.
- Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong 266071, PR China.
- School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, PR China.
ORCID-Profile: Yan-Tuan Li
Förderung
- Natural Science Foundation of Shandong Province
- Development Plan of the Youth Innovation Team in Colleges and Universities of Shandong Province
Zitieren
APA
Yu, Y. M., Li, X. J., Bu, F. Z., Zhao, Z. L., Wu, Z. Y., & Li, Y. T. (2024). Drug–Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy. Molecular Pharmaceutics, 21(11), 5716-5727. https://doi.org/10.1021/acs.molpharmaceut.4c00733
Vancouver
Yu YM, Li XJ, Bu FZ, Zhao ZL, Wu ZY, Li YT. Drug–Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy. Molecular Pharmaceutics. 2024;21(11):5716-5727. doi:10.1021/acs.molpharmaceut.4c00733
BibTeX
@article{Yu2024,
author = {Yu, Yue-Ming and Li, Xue-Jie and Bu, Fan-Zhi and Zhao, Zhi-Long and Wu, Zhi-Yong and Li, Yan-Tuan},
title = {Drug–Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {11},
pages = {5716--5727},
doi = {10.1021/acs.molpharmaceut.4c00733}
}
EUVIMED